KARIM MANSOUR: Open Payments
NPI 1942238878 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$350 in 15 payments from 7 companies in 2025. Trend: 2023 $442 · 2024 $163 · 2025 $350
Food & beverage: $350
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $89 |
| PFIZER INC. | 3 | $78 |
| Boston Scientific Corporation | 1 | $56 |
| Novo Nordisk Inc | 3 | $55 |
| ABIOMED | 2 | $42 |
| ABBVIE INC. | 1 | $16 |
| Seqirus USA Inc | 1 | $14 |
Products named: MOUNJARO, WaveWriter Alpha Prime 16, PREVNAR 20, Wegovy, ELIQUIS, JARDIANCE, Rybelsus, DALVANCE.
Industry payments across CA — which companies pay providers there.
